Senolytic Combination of Dasatinib and Quercetin Alleviates Intestinal Senescence and Inflammation and Modulates the Gut Microbiome in Aged Mice. (6th January 2021)

• Record Type: Journal Article
• Authors: Saccon, Tatiana Dandolini; Nagpal, Ravinder; Yadav, Hariom; Cavalcante, Marcelo Borges; Nunes, Allancer Divino de Carvalho; Schneider, Augusto; Gesing, Adam; Hughes, Brian; Yousefzadeh, Matthew; Tchkonia, Tamar; Kirkland, James L; Niedernhofer, Laura J; Robbins, Paul D; Masternak, Michal M
• Editors: Anderson, Rozalyn M
• Is Part Of: Journals of gerontology. Volume 76:Number 11(2021)
• Page Start: 1895
• Page End: 1905
• Publication Date: 2021-01-06
• Subjects: Biology of aging -- Cellular senescence -- Longevity -- Microbiome -- Microbiota; Geriatrics -- Periodicals; Gerontology -- Periodicals; 618.97
• DOI: 10.1093/gerona/glab002
• Languages: English
• ISSNs: 1079-5006

Abstract

Abstract: Cellular senescence contributes to age-related disorders including physical dysfunction, disabilities, and mortality caused by tissue inflammation and damage. Senescent cells accumulate in multiple tissues with aging and at etiological sites of multiple chronic disorders. The senolytic drug combination, Dasatinib plus Quercetin (D+Q), is known to reduce senescent cell abundance in aged mice. However, the effects of long-term D+Q treatment on intestinal senescent cell and inflammatory burden and microbiome composition in aged mice remain unknown. Here, we examine the effect of D+Q on senescence ( p16 Ink4a and p21 Cip1 ) and inflammation ( Cxcl1, Il1β, Il6, Mcp1, and Tnfα ) markers in small (ileum) and large (caecum and colon) intestine in aged mice ( n = 10) compared to age-matched placebo-treated mice ( n = 10). Additionally, we examine microbial composition along the intestinal tract in these mice. D+Q-treated mice show significantly lower senescent cell ( p16 and p21 expression) and inflammatory ( Cxcl1, Il1β, Il6, Mcp1, and Tnfα expression) burden in small and large intestine compared with control mice. Further, we find specific microbial signatures in ileal, cecal, colonic, and fecal regions that are distinctly modulated by D+Q, with modulation being most prominent in small intestine. Further analyses reveal specific correlation of senescence and inflammation markers with specific microbial signatures. Together, these data demonstrate that the senolytic treatment reduces intestinal senescence and inflammation while altering specific microbiota signatures and suggest that the optimized senolytic regimens might improve health via reducing intestinal senescence, inflammation, and microbial dysbiosis in older subjects.